病例报告:Takotsubo心肌病和超炎症患者的辅助血吸血疗法
1Department of Critical Care Medicine, Pacifica Salud Hospital, Panama City, Panama.
Frontiers in medicine
|October 9, 2025
概括
本案例研究探讨了在重症患者中引发炎症的Takotsubo心肌病变 (TCM). 血液吸收疗法 (CytoSorb) 显示出在高炎症期间稳定血液动力学和改善器官功能方面的潜力.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
- 免疫学 免疫学 免疫学
背景情况:
- 塔科茨博心肌病 (TCM) 是一种与压力有关的心脏功能障碍,通常模仿急性冠状动脉综合征.
- 虽然压力是已知的触发因素,但炎症或传染性刺激在TCM中的作用不太清楚.
- 严重疾病中的系统性炎症可能会恶化心脏功能障碍并导致多器官衰竭.
研究的目的:
- 要呈现一个疑似炎症触发的TCM病例,并迅速恶化.
- 评估血液吸收疗法在管理与TCM相关的高炎症方面的潜在益处.
主要方法:
- 一名77岁的女性患者患有并发症,出现心脏骤停和TCM.
- 怀疑高炎症导致在标准护理的同时启动血液吸收疗法 (CytoSorb).
- 血液动力学,器官功能和乳酸水平被监测.
主要成果:
- 患者在血液吸收后48小时内经历了血液动力学,器官功能和尿液输出的明显改善.
- 没有需要脏替代疗法.
- 患者成功地被抽管并出院.
结论:
- 这一案例表明,血液吸收可能是选择重症患者的可行补充,疑似高炎症相关的TCM.
- 在处理如此复杂的病例时,早期考虑血液吸收可能是有益的.
- 需要进一步的研究来确定因果关系,并确定血吸在TCM中的作用.
相关概念视频
Myocarditis I: Introduction
647
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
647
Myocarditis III: Medical Management
346
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
346
Myocarditis IV: Nursing Management
400
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
400
Heart Failure VI: Adjunct Therapies
635
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
635
Cardiomyopathy II: Dilated Cardiomyopathy
802
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
802
Cardiomyopathy III: Hypertrophic Cardiomyopathy
812
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812


